Significance of docetaxel-based chemotherapy as treatment for metastatic castration-resistant prostate cancer in Japanese men over 75 years old
Author:
Publisher
Springer Science and Business Media LLC
Subject
Urology,Nephrology
Link
http://link.springer.com/content/pdf/10.1007/s11255-012-0223-z.pdf
Reference20 articles.
1. Matsuda T, Marugame T, Kamo K, Katanoda K, Ajiki W, Sobue T (2011) Cancer incidence and incidence rates in Japan in 2005: based on data from 12 population-based cancer registries in the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol 41:139–147
2. Cancer Registration Committee of the Japanese Urological Association (2005) Clinicopathological statistics on registered prostate cancer patients in Japan: 2000 report from the Japanese Urological Association. Int J Urol 12:46–61
3. Donkena KV, Yuan H, Young CY (2010) Recent advances in understanding hormonal therapy resistant prostate cancer. Curr Cancer Drug Targets 10:402–410
4. Beltran H, Beer TM, Carducci MA et al (2011) New therapies for castration-resistant prostate cancer: efficacy and safety. Eur Urol 60:279–290
5. Droz JP, Balducci L, Bolla M et al (2010) Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology. BJU Int 106:462–469
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metastatic stage vs complications at radical nephrectomy with inferior vena cava thrombectomy;Surgical Oncology;2022-06
2. Effect of Chemotherapy on Overall Survival in Contemporary Metastatic Prostate Cancer Patients;Frontiers in Oncology;2021-11-23
3. Improvement in overall and cancer‐specific survival in contemporary, metastatic prostate cancer chemotherapy exposed patients;The Prostate;2021-09-15
4. Prognostic significance of third-line treatment for patients with metastatic castration-resistant prostate cancer: comparative assessments between cabazitaxel and other agents;International Journal of Clinical Oncology;2021-07-13
5. Sequential Docetaxel in ≥7 Cycles Followed by Cabazitaxel Improves Oncological Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer;The Scientific World Journal;2021-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3